Forte Biosciences, Inc.
FBRX
$6.32
-$0.34-5.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.37M | 16.36M | 24.50M | 30.44M | 37.13M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.65M | 1.03M | 900.00K | 825.00K | 1.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 336.00K | 274.00K | 313.00K | 233.00K | 165.00K |
| Total Current Assets | 61.35M | 17.67M | 25.71M | 31.50M | 38.33M |
|
|
|||||
| Total Current Assets | 61.35M | 17.67M | 25.71M | 31.50M | 38.33M |
| Net Property, Plant & Equipment | 77.00K | 86.00K | 96.00K | 106.00K | 109.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 138.00K | 192.00K | 271.00K | 409.00K | 544.00K |
| Total Assets | 61.56M | 17.95M | 26.08M | 32.02M | 38.98M |
|
|
|||||
| Total Accounts Payable | 4.88M | 5.16M | 5.28M | 1.69M | 1.42M |
| Total Accrued Expenses | 4.20M | 3.42M | 3.84M | 1.65M | 2.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.08M | 8.58M | 9.12M | 3.33M | 3.67M |
|
|
|||||
| Total Current Liabilities | 9.08M | 8.58M | 9.12M | 3.33M | 3.67M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.08M | 8.58M | 9.12M | 3.33M | 3.67M |
|
|
|||||
| Common Stock & APIC | 206.47M | 156.21M | 155.42M | 154.63M | 153.83M |
| Retained Earnings | -154.00M | -146.84M | -138.45M | -125.94M | -118.52M |
| Treasury Stock & Other | 11.00K | 1.00K | -7.00K | -2.00K | 4.00K |
| Total Common Equity | 52.48M | 9.37M | 16.96M | 28.69M | 35.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 52.48M | 9.37M | 16.96M | 28.69M | 35.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.48M | 9.37M | 16.96M | 28.69M | 35.31M |
|
|
|||||